On Tuesday, the FDA approved the updated Novavax COVID-19 vaccine. The shot is expected to roll out weeks after updated vaccines from Pfizer’s and Moderna’s
Novavax’s single-strain vaccine targets omicron subvariant XBB.1.5, for emergency use in people ages 12 and up.
The Centers for Disease Control and Prevention is now including Novavax’s shot in the same recommendation it issued last month for updated vaccines from Pfizer and Moderna. That recommendation says all Americans ages six months and older can receive an updated Covid jab.
Novavax announced that doses of the shot will likely be available within the next few days.